Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Dollar and Under Sleeper Stocks -- Ignore unavailable to you. Want to Upgrade?

To: Ga Bard who wrote (4921)	3/3/1998 3:15:00 PM
From: Johnny X	Read Replies (1) \| Respond to of 8835

Here's a company that I believe is going to pay off well for both short-term and long-term investors. Since I've been reading this thread and benefited from it, I thought I ought to share it with you. It's Aqua 1 Beverage Company, located in Vancouver and traded on the Vancouver stock exchange (avoiding some Bulletin Board problems). Here's what I've posted about it today, with a link to the investor relations site (where you can check out the newsletter, and find the 800 number to contact them). The distributor "Beverage Associates" and Aqua 1 Beverage Company have come to an agreement in detail about distribution of the products Super Charge and Brain Wave in the northeastern U.S.. BA projects five million dollars in sales this year. They are apparently as happy with the product as I and some others who've been able to taste it and feel its affect. Some companies which they distribute to include: Grand Union -------- 135 stores Price Chopper ------- 145 stores Hamnaford Brothers -- 132 stores Stewart's ---------- 210 stores Jethro's ---------- 10 stores Wegman's ---------- 47 stores BA also distributes to Sysco Food Services, which is one of the largest distributors in the United States. IMHO, those who wait to buy a full position in the stock are running out of time to buy it under $1.00. Remember, this company has little debt and is a going and growing concern. Since over-hype is not a part of their strategy, it may not double in one day (though it has doubled in just a few days in the past), but I wouldn't be surprised if we see that happen soon. It is definitely going to become a known quantity to those who are not presently stockholders, and will want to be. Then it will move rapidly! Of course, as you all know, I'm a long-term investor. For long-term investors who buy at these prices and are willing to wait twelve months (or 18 months for the capital gains advantage), this company looks that much more attractive, by about a ten times. Here's a link to the investor relations site, where there is a newsletter and a toll-free number to call them. Ask for Investor Relations. The phone number is: 1 (800) 680-6435. aqua-1.com

To: Ga Bard who wrote (4921)	3/3/1998 3:18:00 PM
From: Jim B	Respond to of 8835

Tuesday March 3, 9:04 am Eastern Time Company Press Release New Lung Cancer Treatment Part of Proprietary Technology Reported by Advanced Optics Electronics Inc. ALBUQUERQUE, N.M.--(BUSINESS WIRE)--March 3, 1998--Advanced Optics Electronics, Inc. (OTC BB: ADOT - news), today reported that Biomoda, Inc. (a bio-technology company in which Advanced Optics has a significant minority interest) has announced the completion of an advanced proprietary imaging and treatment program for lung cancer. This treatment was developed concurrently with the early cancer detection test announced by Advanced Optics on February 25. Research on both the early cancer detection test and the proprietary imaging and treatment program was conducted at Los Alamos National Laboratories in New Mexico, the University of New Mexico at Albuquerque, and St. Mary's Hospital and Medical Center in Grand Junction, Colorado. Biomoda, Inc.'s research scientists, in conjunction with the University of California, have adapted their patented molecular marker/binder technology (utilized to create the earliest cancer detection test available) to generate this uniquely integrated treatment for lung cancer. The early detection cancer test can be expected to improve 5-year survival rates from at least 13% to 46%. With the advent of Biomoda's new lung cancer treatment, this diagnostic/treatment program can be expected to increase these survival rates even further. Public testing of this research will soon begin at a respected cytopathology lab in Scottsdale, Ariz. This press release contains forward-looking statements with respect to the results of operations and business of the Company that involves risk and uncertainties. Risks and uncertainties of the Company will be detailed from time to time in the Company's periodic reports to be filed with the Securities and Exchange Commission. Contact Advanced Optics Electronics, Inc. at (505) 797-7878 or for further information visit their web site at www.adot.org. -------------------------------------------------------------------------------- Contact: Advanced Optics Electronics Inc., Albuquerque 505/797-7878 -------------------------------------------------------------------------------- what do you think of this GaBard??? looks great to me.. GO FAMH and HNLY!! jim

To: Ga Bard who wrote (4921)	3/3/1998 3:18:00 PM
From: Mr. Stress	Respond to of 8835

POSITIVE EARNINGS OUT ON HNLY AS PROMISED!!!!! Tuesday March 3, 2:44 pm Eastern Time Company Press Release The Henley Group Announces Magra's First Quarter Results MIAMI--(BUSINESS WIRE)--March 3, 1998--The Henley Group Inc. (NASD BB: HNLY - news) announced Tuesday that Magra Computer Technologies of Toronto (MGRA - Canadian Dealer Network), released first quarter '98 financial results for the period ended Dec. 31, 1997. Sales for the first quarter were $804,719 (Cnd $) as compared to $202,898 for the same period in 1996. Gross Profit was $281,587 as compared to $89,880. Net loss for the period was $59,138 as compared to $199,136. The Net Loss in the period is attributed to the purchase of equipment, the expanding of its offices, and the hiring of additional sales personnel necessary for the expansion efforts presently underway. The acquisition by Henley of 64% of the stock of Magra is through its wholly owned subsidiary M.A.P. Inc. of Canada. Commenting on Magra's first quarter's numbers, Henley's President and CEO stated: ''We are thrilled with the growth Magra is experiencing. Magra, in addition to our other subsidiaries (MC Technologies & M.A.P. Inc.) will contribute to Henley's future expansion. Henley's first quarter results ending March 31 will be reported to the SEC & NASDAQ by filing its quarterly report. This will be Henley's first reporting quarter to the SEC & NASDAQ. Henley anticipates making application to NASDAQ for listing on the Nasdaq Small Cap Market(sm) as soon as it meets all of NASDAQ requirements. The Henley Group is a fast-growing holding company headquartered in Miami specializing in new technologies to provide software applications and systems integration for digital information. Henley actively seeks new acquisitions, in the U.S. and abroad. For more information, visit our web sites at www.thehenleygroup.com and www.magra.com.